Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T22:15:40.189Z.
Calculation as of: 2026-10-06T22:15:40.189Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7e7d16b5ba5167ceff619aa020f317ca223699ac3cb4068fa61dc11e0d5c4076
EARNINGS YIELD
N/A
Market Cap
$4.40M
Earnings Yield
N/A
TTM Avg
1.27%
3Y Avg
1.27%
5Y Avg
1.27%
Market Cap
$4.21M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.53M
Earnings Yield
N/A
TTM Avg
106.12%
3Y Avg
106.12%
5Y Avg
106.12%
Market Cap
$3.93M
Earnings Yield
N/A
TTM Avg
120.37%
3Y Avg
120.37%
5Y Avg
120.37%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.32M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | N/A | 1.27% | 1.27% | 1.27% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | N/A | N/A | N/A | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | N/A | N/A | N/A |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | N/A | 106.12% | 106.12% | 106.12% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | N/A | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.69M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $4.71M | N/A | 63.50% | 63.50% | 63.50% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | N/A | 120.37% | 120.37% | 120.37% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
